Lipitor is a brand-name drug that contains the active ingredient atorvastatin. According to DrugPatentWatch [1], the patent for Lipitor expired in 2011, which means that generic versions of the drug are available. This could potentially lead to price matching for the brand-name drug. However, it is important to note that the FDA has issued safety label changes for cholesterol-lowering statin drugs, including Lipitor [2]. These changes include new warnings about the risk of memory loss and confusion, as well as the potential for increased blood sugar levels and the development of type 2 diabetes. It is unclear whether these safety concerns could impact any potential price matching for Lipitor.

According to GoodRx [3], Medicare coverage for Lipitor is limited, and the drug is generally not covered under Part D plans. This could also impact any potential price matching for the drug. It is important to note that individual pharmacies may have their own policies regarding price matching, and it is always a good idea to check with your pharmacy directly for more information.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LIPITOR
[2] https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-important-safety-label-changes-cholesterol-lowering-statin-drugs
[3] https://www.goodrx.com/lipitor/medicare-coverage